Covered recipient · General Payments record
TARUN NARANG
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$11,659.05
- Reported across 669 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,878.35 | 89 |
| Education | $63.23 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $432.19 | 25 |
| Takeda Pharmaceuticals U.S.A., Inc. | $202.27 | 11 |
| Celgene Corporation | $183.14 | 11 |
| 3-D Matrix, Inc. | $144.11 | 1 |
| EVOKE PHARMA, INC. | $137.01 | 6 |
| Medtronic, Inc. | $97.65 | 1 |
| Janssen Biotech, Inc. | $72.47 | 4 |
| Olympus America Inc. | $69.61 | 3 |
| Lilly USA, LLC | $67.36 | 3 |
| Celltrion USA Inc. | $66.84 | 3 |
| GENZYME CORPORATION | $59.77 | 4 |
| Ardelyx, Inc. | $47.50 | 2 |
| Madrigal Pharmaceuticals | $39.56 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $34.98 | 1 |
| Merck Sharp & Dohme Corporation | $30.55 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.45 | 2 |
| SHIELD THERAPEUTICS INC | $28.67 | 1 |
| QOL Medical, LLC | $27.12 | 2 |
| Phathom Pharmaceuticals, Inc. | $24.11 | 1 |
| Sandoz Inc. | $23.19 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $20.96 | 1 |
| Gilead Sciences, Inc. | $19.42 | 1 |
| Ultragenyx Pharmaceutical Inc. | $19.12 | 1 |
| Ferring Pharmaceuticals Inc. | $17.54 | 1 |
| PFIZER INC. | $16.57 | 1 |
| Braintree Laboratories, Inc. | $15.75 | 1 |
| RedHill Biopharma Inc. | $13.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (91)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.